-
Trump's tariffs could raise the cost of generic drugs in the U.S.
The cost of generic drugs for many people could go up if President-elect Donald Trump follows through on his promise to impose sweeping tariffs on products from China and other foreign countries, policy experts say.
-
Medical debt collection: Know your rights
Some medical debt collectors are trying to collect bills that have already been paid. Here are some questions you can ask that can protect your wallet.
-
Clinical trials sparking hope for Alzheimer's patients: ‘Holding my own'
A clinical trial is testing whether an existing drug could benefit patients with Alzheimer’s disease, in hopes of making symptom-improving medication more accessible for people experiencing mild cognitive impairment.
-
Kidney needed: Retired state trooper searching for living donor
More than 100,000 Americans are waiting for a kidney transplant, and we’re hearing from a retired Massachusetts state trooper who is among them.
Follow NBC10 Boston:
https://instagram.com/nbc10boston
https://tiktok.com/@nbc10boston
https://facebook.com/NBC10Boston
https://twitter.com/NBC10Boston -
‘He needs help': This retired Mass. state trooper is in dire need of a kidney
A retired Massachusetts state trooper has spent his life helping others — but now, he’s in need of help as he searches an organ donor following a kidney failure diagnosis. Tom McAnulty lives in Walpole with his wife of over three decades, Kathleen. The two were looking forward to their retired lives, when Tom received life-changing news in 2020. “Out…
-
Surgeons in Philadelphia successfully separate conjoined twin boys
After spending nearly a year at Children’s Hospital of Philadelphia, conjoined twins Amari and Javar Ruffin were successfully separated.
-
Remember the prescription drug shortages from last year? The problem hasn't gone away
Forty years after the Hatch-Waxman Act created a market for affordable generic versions of prescription medications, it is struggling with persistent shortages.
-
American scientists win Nobel Prize for the discovering of microRNA
Their surprising discovery revealed an entirely new dimension to gene regulation as the microRNAs are proving to be fundamentally important for how organisms develop and function.
-
Maker of Ozempic and Wegovy faces grilling over high cost of weight loss drugs
Is Novo Nordisk helping Americans save taxpayer money or ripping them off? The company’s CEO is scheduled to testify Tuesday on Capitol Hill.
-
New cancer research breakthrough has the potential to save lives
Pancreatic cancer is one of the deadliest forms, but new research could one day lead to lives being saved. Researchers at UMass Chan Medical School in Worcester discovered that using something called nanoparticles can effectively shrink tumors in mice. They hope to someday move this research to human trials and be able to save lives. “If we are successful and…
-
New pancreatic cancer treatment developed at UMass
Researchers in Massachusetts have discovered that using nanoparticles to deliver drugs can shrink tumors in mice.
-
Mass. is the No. 1 state for biotech, but is the boom over?
The biotech industry has become a critical piece of Massachusetts’ economy, but economic headwinds have led to layoffs and empty lab space. MassBio has released a new industry snapshot saying that those layoffs have been offset by new jobs.
-
With a ‘target' on its back, here's how Mass. plans to keep its edge in biotech
Greater Boston — particularly Kendall Square in Cambridge and more recently the Seaport District — has become a global leader in the biotech industry over the past decade and a half, but do the hundreds of local layoffs signify a threat to what has become a critical piece of Massachusetts’ economy? Likely not, say industry leaders, rather, they explain that…
-
Eli Lilly's weight loss drug slashes the risk of developing diabetes in long-term trial
The late-stage trial on tirzepatide also found that patients experienced sustained weight loss over the roughly three-year treatment period.
-
US challenges ‘bogus' patents on Ozempic and other drugs in effort to spur competition
Federal regulators on Tuesday sent warning letters to several drugmakers, taking issue with patents on popular drugs for weight loss, diabetes, asthma and other respiratory conditions.
-
AI pharmacist? Brigham study tests how new tech can help manage patient meds
Many of us need to take medication everyday, and for some people, it’s a lengthy daily regimen of prescriptions to manage our health. It can be an overwhelming workload, though, for doctors and pharmacists to track all of their patients’ prescriptions, according to Dr. Lisa Rotenstein. She is a primary care provider, who previously worked at Boston’s Brigham and...
-
AI pharmacist? Brigham testing new tech to assist docs, pharmacists
FeelBetter is teaming up with Brigham and Women’s Hospital to bring their AI tech to patients here in Greater Boston.
Follow NBC10 Boston on…
Instagram: instagram.com/nbc10boston
TikTok: tiktok.com/@nbc10boston
Facebook: facebook.com/NBC10Boston
X: twitter.com/NBC10Boston -
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It's not that clear-cut
President Joe Biden often overstates what people who are eligible for the price cap for insulin paid previously.
-
3 signs it's time to break up with your doctor—'your health is one of your most important assets,' physician says
A doctor who was once a good fit might not always meet the needs you have now. Here are some signs that it’s time to find a new one.
-
A popular asthma medication was discontinued, leaving patients scrambling for alternatives
Flovent, made by the company GlaxoSmithKline, was discontinued at the end of December. It was used to treat asthma in both children and adults, and many are now struggling to find the medication they need to breathe.